Allschwil, Switzerland

Jean-Jacques Sanglier

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Jacques Sanglier. Retrieved from https://idiyas.com/inventor/jean-jacques-sanglier-sk5ruh76

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Jean-Jacques Sanglier

Introduction

Jean-Jacques Sanglier is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on macrolides. With a single patent to his name, his influence in the industry is underscored by his position at Novartis AG.

Latest Patents

Sanglier's most prominent patent is for a novel class of macrolides, which are essential components in the development of antibiotics and other therapeutic drugs. This innovation reflects his deep commitment to advancing medical science and improving healthcare.

Career Highlights

Throughout his career at Novartis AG, Jean-Jacques has focused on research and development that drives impactful advancements in medicine. His dedication to innovation has solidified his reputation as a skilled inventor within his field.

Collaborations

In his endeavors, Sanglier has collaborated with talented colleagues, including Theodor Fehr and Lukas Oberer. These collaborations have fostered a creative environment leading to breakthroughs and advancements in pharmaceutical research.

Conclusion

Jean-Jacques Sanglier stands out as an inspiring figure in the world of innovation. His work in developing new macrolides demonstrates his commitment to enhancing healthcare and showcases the important role of inventors in shaping the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…